Search for "glycosyl fluoride" in Full Text gives 7 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2021, 17, 1981–2025, doi:10.3762/bjoc.17.129
Graphical Abstract
Figure 1: Overview of the methods available for the synthesis of polysaccharides. For each method, advantages...
Figure 2: Overview of the classes of polysaccharides discussed in this review. Each section deals with polysa...
Scheme 1: Enzymatic and chemical polymerization approaches provide cellulose oligomers with a non-uniform dis...
Scheme 2: AGA of a collection of cellulose analogues obtained using BBs 6–9. Specifically placed modification...
Figure 3: Chemical structure of the different branches G, X, L, F commonly found in XGs. Names are given foll...
Scheme 3: AGA of XG analogues with defined side chains. The AGA cycle includes coupling (TMSOTf), Fmoc deprot...
Figure 4: Synthetic strategies and issues associated to the formation of the β(1–3) linkage.
Scheme 4: Convergent synthesis of β(1–3)-glucans using a regioselective glycosylation strategy.
Scheme 5: DMF-mediated 1,2-cis glycosylation. A) General mechanism and B) examples of α-glucans prepared usin...
Scheme 6: Synergistic glycosylation strategy employing a nucleophilic modulation strategy (TMSI and Ph3PO) in...
Scheme 7: Different approaches to produce xylans. A) Polymerization techniques including ROP, and B) enzymati...
Scheme 8: A) Synthesis of arabinofuranosyl-decorated xylan oligosaccharides using AGA. Representative compoun...
Scheme 9: Chemoenzymatic synthesis of COS utilizing a lysozyme-catalyzed transglycosylation reaction followed...
Scheme 10: Synthesis of COS using an orthogonal glycosylation strategy based on the use of two different LGs.
Scheme 11: Orthogonal N-PGs permitted the synthesis of COS with different PA.
Scheme 12: AGA of well-defined COS with different PA using two orthogonally protected BBs. The AGA cycle inclu...
Scheme 13: A) AGA of β(1–6)-N-acetylglucosamine hexasaccharide and dodecasaccharide. AGA includes cycles of co...
Figure 5: ‘Double-faced’ chemistry exemplified for ᴅ-Man and ʟ-Rha. Constructing β-Man linkages is considerab...
Figure 6: Implementation of a capping step after each glycosylation cycle for the AGA of a 50mer oligomannosi...
Scheme 14: AGA enabled the synthesis of a linear α(1–6)-mannoside 100mer 93 within 188 h and with an average s...
Scheme 15: The 151mer branched polymannoside was synthesized by a [30 + 30 + 30 + 30 + 31] fragment coupling. ...
Figure 7: PG stereocontrol strategy to obtain β-mannosides. A) The mechanism of the β-mannosylation reaction ...
Scheme 16: A) Mechanism of 1,2-cis stereoselective glycosylation using ManA donors. Once the ManA donor is act...
Figure 8: A) The preferred 4H3 conformation of the gulosyl oxocarbenium ion favors the attack of the alcohol ...
Scheme 17: AGA of type I rhamnans up to 16mer using disaccharide BB 115 and CNPiv PG. The AGA cycle includes c...
Figure 9: Key BBs for the synthesis of the O-antigen of Bacteroides vulgatus up to a 128mer (A) and the CPS o...
Figure 10: Examples of type I and type II galactans synthesized to date.
Figure 11: A) The DTBS PG stabilizes the 3H4 conformation of the Gal oxocarbenium ion favoring the attack of t...
Figure 12: Homogalacturonan oligosaccharides synthesized to date. Access to different patterns of methyl-ester...
Figure 13: GlfT2 from Mycobacterium tuberculosis catalyzes the sequential addition of UPD-Galf donor to a grow...
Figure 14: The poor reactivity of acceptor 137 hindered a stepwise synthesis of the linear galactan backbone a...
Scheme 18: AGA of a linear β(1–5) and β(1–6)-linked galactan 20mer. The AGA cycle includes coupling (NIS/TfOH)...
Figure 15: The 92mer arabinogalactan was synthesized using a [31 + 31 + 30] fragment coupling between a 31mer ...
Scheme 19: Synthesis of the branched arabinofuranose fragment using a six component one-pot synthesis. i) TTBP...
Figure 16: A) Chemical structure and SNFG of the representative disaccharide units forming the GAG backbones, ...
Figure 17: Synthetic challenges associated to the H/HS synthesis.
Scheme 20: Degradation of natural heparin and heparosan generated valuable disaccharides 150 and 151 that can ...
Scheme 21: A) The one-step conversion of cyanohydrin 156 to ʟ-iduronamide 157 represent the key step for the s...
Scheme 22: A) Chemoenzymatic synthesis of heparin structures, using different types of UDP activated natural a...
Scheme 23: Synthesis of the longest synthetic CS chain 181 (24mer) using donor 179 and acceptor 180 in an iter...
Scheme 24: AGA of a collection of HA with different lengths. The AGA cycle includes coupling (TfOH) and Lev de...
Beilstein J. Org. Chem. 2021, 17, 964–976, doi:10.3762/bjoc.17.78
Graphical Abstract
Scheme 1: Scope of glycosyl acceptors for glycosylation with pivaloyl-protected mannosyl fluoride α-1a in liq...
Scheme 2: Glycosylation of binucleophiles 7a,b in liquid SO2.
Scheme 3: Pivaloyl-protected glucosyl fluoride β-9 as a glycosyl donor in liquid SO2.
Scheme 4: Benzyl protected manno- and glucopyranosyl fluorides α-15 and 16 as glycosyl donors in liquid SO2. ...
Scheme 5: 2-Deoxy glycosyl fluoride α-19 as a glycosyl donor in liquid SO2.
Figure 1: Detection of the FSO2− species by 19F NMR (471 MHz, D2O).
Figure 2: Computational study of reaction mechanism α-11 + MeOH → α-13c in the presence of and in absence of ...
Beilstein J. Org. Chem. 2018, 14, 416–429, doi:10.3762/bjoc.14.30
Graphical Abstract
Scheme 1: The first ENGase-catalysed glycosylation of a GlcNAc acceptor using an N-glycan oxazoline as donor.
Scheme 2: Production of N-glycan oxazolines from peracetylated sugars using Lewis acids.
Scheme 3: Direct conversion of unprotected GlcNAc to a glycosyl oxazoline by treatment with DMC and Et3N in w...
Scheme 4: Total synthesis of a truncated complex biantennary N-glycan oxazoline via an epimerisation approach...
Scheme 5: Wangs’s total synthesis of an N-glycan oxazoline incorporating click handles, employing Crich direc...
Scheme 6: Wangs’s total synthesis of an N-glycan dodecasaccharide oxazoline employing final step oxazoline fo...
Scheme 7: Production of a phosphorylated N-glycan oxazoline, employing final step oxazoline formation with DM...
Scheme 8: Enzymatic degradation of locust bean gum, and chemical conversion into an N-glycan dodecasaccharide...
Scheme 9: Production of a complex biantennary N-glycan oxazoline from hens’ eggs by semi-synthesis via isolat...
Scheme 10: Production of a high mannose (Man-9) N-glycan oxazoline from soy bean flour.
Scheme 11: Production of a triantennary N-glycan oxazoline from bovine feruin by semi-synthesis.
Beilstein J. Org. Chem. 2017, 13, 2028–2048, doi:10.3762/bjoc.13.201
Graphical Abstract
Scheme 1: The mechanistic outline of the intermolecular (a) and intramolecular (b) glycosylation reactions.
Figure 1: Three general concepts for intramolecular glycosylation reactions.
Scheme 2: First intramolecular glycosylation using the molecular clamping.
Scheme 3: Succinoyl as a flexible linker for intramolecular glycosylation of prearranged glycosides.
Scheme 4: Template-directed cyclo-glycosylation using a phthaloyl linker.
Scheme 5: Phthaloyl linker-mediated synthesis of branched oligosaccharides via remote glycosidation.
Scheme 6: Molecular clamping with the phthaloyl linker in the synthesis of α-cyclodextrin.
Scheme 7: m-Xylylene as a rigid tether for intramolecular glycosylation.
Scheme 8: Oligosaccharide synthesis using rigid xylylene linkers.
Scheme 9: Stereo- and regiochemical outcome of peptide-based linkers.
Scheme 10: Positioning effect of donor and acceptor in peptide templated synthesis.
Scheme 11: Synthesis of a trisaccharide using a non-symmetrical tether strategy.
Scheme 12: Effect of ring on glycosylation with a furanose.
Scheme 13: Rigid BPA template with various linkers.
Scheme 14: The templated synthesis of maltotriose in complete stereoselectivity.
Scheme 15: First examples of the IAD.
Scheme 16: Long range IAD via dimethylsilane.
Scheme 17: Allyl-mediated tethering strategy in the IAD.
Scheme 18: IAD using tethering via the 2-naphthylmethyl group.
Scheme 19: Origin of selectivity in boronic ester mediated IAD.
Scheme 20: Arylborinic acid approach to the synthesis of β-mannosides.
Figure 2: Facial selectivity during HAD.
Scheme 21: Possible mechanisms to explain α and β selectivity in palladium mediated IAD.
Scheme 22: DISAL as the leaving group that favors the intramolecular glycosylation pathway.
Scheme 23: Boronic acid as a directing group in the leaving group-based glycosylation method.
Beilstein J. Org. Chem. 2017, 13, 1239–1279, doi:10.3762/bjoc.13.123
Graphical Abstract
Scheme 1: Solution-state conformations of D-glucose.
Scheme 2: Enzymatic synthesis of oligosaccharides.
Scheme 3: Enzymatic synthesis of a phosphorylated glycoprotein containing a mannose-6-phosphate (M6P)-termina...
Scheme 4: A) Selected GTs-mediated syntheses of oligosaccharides and other biologically active glycosides. B)...
Scheme 5: Enzymatic synthesis of nucleosides.
Scheme 6: Fischer glycosylation strategies.
Scheme 7: The basis of remote activation (adapted from [37]).
Scheme 8: Classic remote activation employing a MOP donor to access α-anomeric alcohols, carboxylates, and ph...
Figure 1: Synthesis of monoprotected glycosides from a (3-bromo-2-pyridyloxy) β-D-glycopyranosyl donor under ...
Scheme 9: Plausible mechanism for the synthesis of α-galactosides. TBDPS = tert-butyldiphenylsilyl.
Scheme 10: Synthesis of the 6-O-monoprotected galactopyranoside donor for remote activation.
Scheme 11: UDP-galactopyranose mutase-catalyzed isomerization of UDP-Galp to UDP-Galf.
Scheme 12: Synthesis of the 1-thioimidoyl galactofuranosyl donor.
Scheme 13: Glycosylation of MeOH using a self-activating donor in the absence of an external activator. a) Syn...
Scheme 14: The classical Lewis acid-catalyzed glycosylation.
Figure 2: Unprotected glycosyl donors used for the Lewis acid-catalyzed protecting group-free glycosylation r...
Scheme 15: Four-step synthesis of the phenyl β-galactothiopyranosyl donor.
Scheme 16: Protecting-group-free C3′-regioselective glycosylation of sucrose with α–F Glc.
Scheme 17: Synthesis of the α-fluoroglucosyl donor.
Figure 3: Protecting-group-free glycosyl donors and acceptors used in the Au(III)-catalyzed glycosylation.
Scheme 18: Synthesis of the mannosyl donor used in the study [62].
Scheme 19: The Pd-catalyzed stereoretentive glycosylation of arenes using anomeric stannane donors.
Scheme 20: Preparation of the protecting-group-free α and β-stannanes from advanced intermediates for stereoch...
Figure 4: Selective anomeric activating agents providing donors for direct activation of the anomeric carbon.
Scheme 21: One-step access to sugar oxazolines or 1,6-anhydrosugars.
Scheme 22: Enzymatic synthesis of a chitoheptaose using a mutant chitinase.
Scheme 23: One-pot access to glycosyl azides [73], dithiocarbamates [74], and aryl thiols using DMC activation and sub...
Scheme 24: Plausible reaction mechanism.
Scheme 25: Protecting-group-free synthesis of anomeric thiols from unprotected 2-deoxy-2-N-acetyl sugars.
Scheme 26: Protein conjugation of TTL221-PentK with a hyaluronan hexasaccharide thiol.
Scheme 27: Proposed mechanism.
Scheme 28: Direct two-step one-pot access to glycoconjugates through the in situ formation of the glycosyl azi...
Scheme 29: DMC as a phosphate-activating moiety for the synthesis of diphosphates. aβ-1,4-galactose transferas...
Figure 5: Triazinylmorpholinium salts as selective anomeric activating agents.
Scheme 30: One-step synthesis of DBT glycosides from unprotected sugars in aqueous medium.
Scheme 31: Postulated mechanism for the stereoselective formation of α-glycosides.
Scheme 32: DMT-donor synthesis used for metal-catalyzed glycosylation of simple alcohols.
Figure 6: Protecting group-free synthesis of glycosyl sulfonohydrazides (GSH).
Figure 7: The use of GSHs to access 1-O-phosphoryl and alkyl glycosides. A) Glycosylation of aliphatic alcoho...
Scheme 33: A) Proposed mechanism of glycosylation. B) Proposed mechanism for stereoselective azidation of the ...
Scheme 34: Mounting GlcNAc onto a sepharose solid support through a GSH donor.
Scheme 35: Lawesson’s reagent for the formation of 1,2-trans glycosides.
Scheme 36: Protecting-group-free protein conjugation via an in situ-formed thiol glycoside [98].
Scheme 37: pH-Specific glycosylation to functionalize SAMs on gold.
Figure 8: Protecting-group-free availability of phenolic glycosides under Mitsunobu conditions. DEAD = diethy...
Scheme 38: Accessing hydroxyazobenzenes under Mitsunobu conditions for the study of photoswitchable labels. DE...
Scheme 39: Stereoselective protecting-group-free glycosylation of D-glucose to provide the β-glucosyl benzoic ...
Figure 9: Direct synthesis of pyranosyl nucleosides from unactivated and unprotected ribose using optimized M...
Figure 10: Direct synthesis of furanosyl nucleosides from 5-O-monoprotected ribose in a one-pot glycosylation–...
Figure 11: Synthesis of ribofuranosides using a monoprotected ribosyl donor via an anhydrose intermediate.
Figure 12: C5′-modified nucleosides available under our conditions.
Scheme 40: Plausible reaction mechanism for the formation of the anhydrose.
Figure 13: Direct glycosylation of several aliphatic alcohols using catalytic Ti(Ot-Bu)4 in the presence of D-...
Figure 14: Access to glycosides using catalytic PPh3 and CBr4.
Figure 15: Access to ribofuranosyl glycosides as the major product under catalytic conditions. aLiOCl4 (2.0 eq...
Beilstein J. Org. Chem. 2014, 10, 2658–2663, doi:10.3762/bjoc.10.279
Graphical Abstract
Figure 1: Pyrenebutanol (3) initiated oligomerization.
Figure 2: Scope of oligomerization.
Beilstein J. Org. Chem. 2008, 4, No. 31, doi:10.3762/bjoc.4.31
Graphical Abstract
Figure 1: Therapeutic antifungal agents.
Figure 2: Structure of sordarin (1) and sordaricin (2).
Scheme 1: Kato’s retrosynthetic plan.
Scheme 2: Synthesis of cyclopentadiene 13.
Scheme 3: Synthesis of sordaricin methyl ester.
Scheme 4: Mander’s retrosynthetic plan.
Scheme 5: Synthesis of iodo compound 27.
Scheme 6: Synthesis of sordaricin (2).
Scheme 7: Retrosynthesis of sordarin and sordaricin.
Scheme 8: Synthesis of ketone 43.
Scheme 9: Synthesis of β-keto ethyl ester 45.
Scheme 10: Synthesis of tetracyclic framework 52.
Scheme 11: Synthesis of sordaricin and sordarin.
Figure 3: Modifications of glycosyl part.
Scheme 12: Simplified model of sordarin.
Scheme 13: Synthesis of cyclopentane analog precursors.
Scheme 14: Synthesis of six cyclopentane analogs.
Scheme 15: Retrosynthetic plan of sordarin analog.
Scheme 16: Synthesis of sordarin analog 98.
Scheme 17: Synthesis of sordarin analog 103.